ISPOR's Annual European Congress to Feature New Outcomes Research from Analysis Group's Health Care Practice
September 28, 2016
Analysis Group will present one workshop and two poster presentations at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)'s 19th Annual European Congress in Vienna, Austria on October 29-November 2, 2016.
Managing Principal Patrick Lefebvre and Analysis Group Associate Maral DerSarkissian will serve as discussion leaders for the workshop, ”Doubly Robust Estimation for Comparative Effectiveness Research: Getting an Extra Shot at Correctly Specifying the Treatment-Outcome Model.” The workshop will include a conceptual overview of doubly robust (DR) estimation, as well as the presentation and discussion of a study using DR estimation to compare the effect of oral versus BRACE therapies on relapse in multiple sclerosis.
Analysis Group research posters will explore the feasibility of matching-adjusted indirect comparison of Omalizumab and Mepolizumab in moderate to severe asthma, as well as the identification of high-value subpopulations for the treatment of heterogeneous rare diseases.
Analysis Group will be a featured exhibitor at the conference.
Read about our presentations